Body Composition Abnormalities in Children with Prader-Willi Syndrome and Long-Term Effects of Growth Hormone Therapy
- 1 July 2000
- journal article
- research article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 53 (4), 200-206
- https://doi.org/10.1159/000023567
Abstract
Obesity and hypothalamic GH deficiency contribute in different ways to the disturbances of body composition in Prader-Willi syndrome (PWS); while both increase the fat compartment, the reduction of lean tissue mass has been attributed mainly to GH deficiency. Therefore, body composition measured by dual-energy X-ray absorptiometry was prospectively studied in 12 overweight children with PWS and weight for height (WfH) SDS >0 before and during 3.5 years of treatment with hGH (0.037 mg/kg/day) on average. In the long term, there is a net reduction of body fat from 3.1 to 1.2 SD, with a minimum at the end of the second year of treatment. WfH SDS correctly reflects body fat mass and its changes. The initial deficit of lean mass (–1.6 SD) is counteracted by GH only during the first year of therapy (increase to –1.25 SD). But in the long term, GH therapy does not further compensate for this deficit, when lean mass is corrected for its growth-related increase. In conclusion, exogenous GH changes the phenotype of children with PWS: fat mass becomes normal, but, at least in the setting studied, GH is not sufficient to normalize lean tissue mass.Keywords
This publication has 7 references indexed in Scilit:
- Growth Hormone Normalises Height, Prediction of Final Height and Hand Length in Children with Prader-Willi Syndrome after 4 Years of TherapyHormone Research in Paediatrics, 2000
- Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndromeThe Journal of Pediatrics, 2000
- Fat Mass in Infants and Toddlers: Comparability of Total Body Water, Total Body Potassium, Total Body Electrical Conductivity, and Dual-Energy X-ray AbsorptiometryJournal of Pediatric Gastroenterology and Nutrition, 1999
- Low-Dose Growth Hormone Treatment with Diet Restriction Accelerates Body Fat Loss, Exerts Anabolic Effect and Improves Growth Hormone Secretory Dysfunction in Obese AdultsHormone Research in Paediatrics, 1999
- Growth Hormone Treatment of Abdominally Obese Men Reduces Abdominal Fat Mass, Improves Glucose and Lipoprotein Metabolism, and Reduces Diastolic Blood PressureJournal of Clinical Endocrinology & Metabolism, 1997
- Persistent lipolytic effect of exogenous growth hormone during caloric restrictionAmerican Journal Of Medicine, 1995
- Energy expenditure and body composition in Prader-Willi syndromeMetabolism, 1988